Ajanta Pharma Ltd share Price

Ajanta Pharma Limited is in the business of manufacturing and marketing speciality pharmaceutical dosages. The company operates in domestic and various international markets, producing a range of products in therapeutic segments, such as anti-biotic, anti-malarial, anti-diabetic, paediatric, orthopaedic, respiratory, and cardiology. The company has its headquarters in Mumbai and offices in the USA, Mauritius, and the Philippines. The company was incorporated in 1979, and its market capitalisation, as of 9 October 2022, is Rs 16,148 crore.

The company is listed on the National Stock Exchange (NSE) under code AJANTPHARM and on the Bombay Stock Exchange (BSE) under code 532331.

Ajanta Pharma Limited currently sells its products in more than 30 countries across the world and has seven state-of-the-art manufacturing facilities in India. The company’s R&D centre has more than 750 scientists who are developing innovative pharmaceutical products for global markets. Over the years, the company has developed a specialisation in developing generic medicines and process chemistry for domestic as well as international markets.

In June 2022, the shareholding pattern of Ajanta Pharma Limited revealed a 70.48% stake by promoters, 10.88% stake in mutual funds, 9.30% stake by retail investors, 8.30% stake by Foreign Institutional Investors, and 1.04% stake by other domestic institutions. The management team of the company includes  Mr  Mannalal B Agarwal (Chairman),  Mr  Madhusudan B Agarwal (Vice-Chairman),  Mr  Yogesh Agarwal (Managing Director),  Mr  Chandrakant M Khetan (Independent Director), and  Mr  Gaurang Shah (Company Secretary), among others.

On 10 October 2022, Ajanta Pharma Limited’s share price closed at Rs 1268.80 at the NSE and Rs 1263.55 at the BSE. The share’s 52-week low and 52-week high prices are Rs 1061.77 and Rs 1577.20, respectively. Ajanta Pharma shares have provided a six-month return of 9.11% and its PE ratio as of 10 October 2022 stood at 22.65, while the PB ratio stood at 0.20. If you want to invest in Ajanta Pharma shares, you can open a demat account with ICICIdirect and place your orders.

Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code :07730), BSE Ltd (Member Code :103) and Member of Multi Commodity Exchange of India Ltd. (Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest.  I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose